Table of Contents
1 Industry Outlook 9
1.1 Industry Overview 9
1.2 Industry Trends 13
2 Report Outline 16
2.1 Report Scope 16
2.2 Report Summary 16
2.3 Research Methodology 17
2.4 Report Assumptions 17
3 Market Snapshot 18
3.1 Total Addressable Market (TAM) 18
3.2 Segmented Addressable Market (SAM) 20
3.3 Related Markets 20
4 Market Outlook 21
4.1 Overview 21
4.2 Porter 5 (Five) Forces 23
4.3 Market Segmentation 24
4.4 Market Dynamics 24
4.4.1 Drivers 25
4.4.1.1 Growing incidence of unwanted pregnancies 25
4.4.1.2 Increase in prevalence of contraception 25
4.4.1.3 Rise in adoption of oral pills and its advantages over other contraceptives 26
4.4.1.4 Government initiatives 27
4.4.1.5 Unmet need for contraception in developing countries 27
4.4.2 Restraints 28
4.4.2.1 Prolonged regulatory approvals of contraceptives 28
4.4.2.2 Cultural and religious opposition 28
4.4.2.1 Availability of low cost generic contraceptives 28
4.4.2.2 Limited knowledge about modern contraceptives 28
4.4.2.3 Intense competition among vendors 29
4.4.3 Opportunities 29
4.4.3.1 Technological advancements 29
4.4.3.2 Rise in effective awareness programs 30
4.4.3.3 High demand of cheap contraceptives 30
4.4.3.4 Increase in mergers and acquisition 30
4.4.3.5 Increase in healthcare spending 30
4.4.4 DRO - Impact Analysis 31
4.4.5 Key Stakeholders 32
5 Market Segmentation by Product Types: Market Size & Analysis 32
5.1 Overview 32
5.1.1 Market Size and Analysis 32
5.2 Contraceptive Drugs Market 35
5.3 Contraceptive Devices Market 37
5.4 Global Condom Market 39
5.4.1 Global IUD Market 39
5.4.1.1 Overview 39
5.4.2 Global sub-dermal Implants 40
5.4.2.1 Overview 40
5.4.3 Global Vaginal Rings Market 41
5.4.3.1 Overview 41
5.4.4 Global Non-Surgical Permanent Contraceptive Market 41
5.4.4.1 Overview 41
5.4.5 Global Diaphragms Market 42
5.4.5.1 Overview 42
5.4.6 Global Sponges Market 42
5.4.6.1 Overview 44
6 Regions: Market Size & Analysis 45
6.1 North America 46
6.1.1 Market Overview 46
6.2 Europe 47
6.2.1 Market Overview 47
6.3 APAC 49
6.3.1 Market Overview 49
6.4 Rest of the World 50
6.4.1 Market Overview 50
7 Competitive Landscape 53
7.1 Competitor Comparison Analysis 53
8 Vendor Profiles 55
8.1.1 Allergan plc 55
8.1.1.1 Overview 55
8.1.1.2 Business unit 58
8.1.1.3 Business focus 59
8.1.1.4 SWOT analysis 59
8.1.1.5 Business strategies 60
8.1.2 Bayer AG 61
8.1.2.1 Overview 61
8.1.2.2 Business unit 63
8.1.2.3 Business focus 64
8.1.2.4 SWOT analysis 65
8.1.2.5 Business strategies 66
8.1.3 Merck & Co.' Inc. 66
8.1.3.1 Overview 66
8.1.3.2 Business unit 68
8.1.3.3 Business focus 69
8.1.3.4 SWOT analysis 69
8.1.3.5 Business strategies 71
8.1.4 Teva Pharmaceutical Industries Ltd 71
8.1.4.1 Overview 71
8.1.4.2 Business unit 74
8.1.4.3 Business focus 75
8.1.4.4 SWOT analysis 75
8.1.4.5 Business strategies 76
8.1.5 Church & Dwight 77
8.1.5.1 Overview 77
8.1.5.2 Business unit 78
8.1.5.3 Business focus 79
8.1.5.4 SWOT analysis 79
8.1.5.5 Business strategies 80
Annexure 81
? Acronyms 81